• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有羟丙基支链的脂质体 Fe(III)大环配合物作为 MRI 探针。

Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes.

机构信息

Department of Chemistry, The State University of New York at Buffalo, Buffalo, New York 14260, United States.

Department of Chemistry, Faculty of Science, Mansoura University, El-Gomhoria Street, 35516 Mansoura, Egypt.

出版信息

ACS Appl Bio Mater. 2021 Nov 15;4(11):7951-7960. doi: 10.1021/acsabm.1c00879. Epub 2021 Oct 15.

DOI:10.1021/acsabm.1c00879
PMID:35006776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9124523/
Abstract

Paramagnetic liposomes containing Fe(III) complexes were prepared by incorporation of mononuclear (Fe(L1) or Fe(L3)) or dinuclear (Fe(L2)) coordination complexes of 1,4,7-triazacyclononane macrocycles containing 2-hydroxypropyl pendant groups. Two different types of paramagnetic liposomes were prepared. The first type, LipoA, has the mononuclear Fe(L1) complex loaded into the internal aqueous core. The second type, LipoB, has the amphiphilic Fe(L3) complex inserted into the liposomal bilayer and the internal aqueous core loaded with either Fe(L1) (LipoB1) or Fe(L2) (LipoB2). LipoA enhances both T and T water proton relaxation rates. Treatment of LipoA with osmotic gradients to produce a nonspherical liposome produces a liposome with a chemical exchange saturation transfer effect as shown by an asymmetry analysis but only at high osmolarity. LipoB1, which contains an amphiphilic complex in the liposomal bilayer, produced a broadened Z-spectrum upon treatment of the liposome with osmotic gradients. The relaxivity of LipoB1 and LipoB2 were higher than the relaxivity of LipoA on a per Fe basis, suggesting an important contribution from the amphiphilic Fe(III) center. The relaxivities of paramagnetic liposomes are relatively constant over a range of magnetic field strengths (1.4-9.4 T), with the ratio of / substantially increasing at high field strengths. MRI studies of LipoB1 in mice showed prolonged contrast enhancement in blood compared to the clinically employed Gd(DOTA), which was injected at a 2-fold higher dose per metal than the Fe(III)-loaded liposomes.

摘要

载有 Fe(III) 配合物的超顺磁脂质体是通过将单核 (Fe(L1) 或 Fe(L3)) 或双核 (Fe(L2)) 配合物的 1,4,7-三氮杂环壬烷大环配合物整合到含有 2-羟丙基侧基的内部水核心中制备的。制备了两种不同类型的超顺磁脂质体。第一种,LipoA,将单核 Fe(L1) 配合物载入内部水核心。第二种,LipoB,将两亲性 Fe(L3) 配合物插入脂质体双层中,内部水核心载入 Fe(L1) (LipoB1) 或 Fe(L2) (LipoB2)。LipoA 增强了 T 和 T 水质子弛豫率。用渗透压梯度处理 LipoA 产生非球形脂质体,通过不对称分析显示出化学交换饱和转移效应,但仅在高渗透压下。LipoB1 含有两亲性配合物在脂质体双层中,在渗透压梯度处理脂质体时产生了一个展宽的 Z 谱。与 LipoA 相比,LipoB1 和 LipoB2 的 弛豫率更高,这表明两亲性 Fe(III) 中心有重要贡献。超顺磁脂质体的弛豫率在磁场强度范围内(1.4-9.4 T)相对恒定,在高磁场强度下 / 的比值显著增加。在小鼠中进行的 LipoB1 的 MRI 研究显示,与临床上使用的 Gd(DOTA)相比,血液中的对比增强时间延长,Gd(DOTA) 的注射剂量是铁(III)负载脂质体的两倍。

相似文献

1
Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes.具有羟丙基支链的脂质体 Fe(III)大环配合物作为 MRI 探针。
ACS Appl Bio Mater. 2021 Nov 15;4(11):7951-7960. doi: 10.1021/acsabm.1c00879. Epub 2021 Oct 15.
2
Liposomal MRI probes containing encapsulated or amphiphilic Fe(III) coordination complexes.脂质体 MRI 探针,含有包裹或两亲性 Fe(III)配位配合物。
Biomater Sci. 2023 Aug 22;11(17):5942-5954. doi: 10.1039/d3bm00029j.
3
Dinuclear Fe(III) Hydroxypropyl-Appended Macrocyclic Complexes as MRI Probes.双核 Fe(III) 羟丙基修饰大环配合物作为 MRI 探针。
Inorg Chem. 2021 Jun 21;60(12):8651-8664. doi: 10.1021/acs.inorgchem.1c00634. Epub 2021 Jun 10.
4
Distinct Coordination Chemistry of Fe(III)-Based MRI Probes.基于 Fe(III) 的 MRI 探针的独特配位化学。
Acc Chem Res. 2022 May 17;55(10):1435-1444. doi: 10.1021/acs.accounts.2c00102. Epub 2022 Apr 28.
5
Fe(III) MRI Probes Containing Phenolate or Hydroxypyridine-Appended Triamine Chelates and a Coordination Site for Bound Water.含苯并菲或羟吡啶取代三胺螯合物和结合水配位位的 Fe(III) MRI 探针。
Inorg Chem. 2023 Oct 9;62(40):16513-16522. doi: 10.1021/acs.inorgchem.3c02344. Epub 2023 Sep 25.
6
Comparison of phosphonate, hydroxypropyl and carboxylate pendants in Fe(III) macrocyclic complexes as MRI contrast agents.比较膦酸酯、羟丙基和羧酸酯侧基在 Fe(III)大环配合物作为 MRI 造影剂中的性能。
J Inorg Biochem. 2021 Dec;225:111594. doi: 10.1016/j.jinorgbio.2021.111594. Epub 2021 Aug 28.
7
Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups.通过附加磺酸基或羟基调节 Fe(III)大环 MRI 对比剂的性质。
Molecules. 2020 May 13;25(10):2291. doi: 10.3390/molecules25102291.
8
A Class of Fe Macrocyclic Complexes with Alcohol Donor Groups as Effective T MRI Contrast Agents.一类具有醇供体基团的 Fe 大环配合物作为有效的 T1 MRI 对比剂。
Angew Chem Int Ed Engl. 2020 Feb 3;59(6):2414-2419. doi: 10.1002/anie.201912273. Epub 2019 Dec 20.
9
Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.利用多功能磁共振和热敏脂质体实现剂量控制的磁热刺激药物释放
Nanotheranostics. 2019 Apr 19;3(2):166-178. doi: 10.7150/ntno.31164. eCollection 2019.
10
Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity.顺磁性脂质体作为磁共振成像造影剂:脂质体物理化学性质对体外弛豫率的影响
Magn Reson Imaging. 1999 Jan;17(1):83-9. doi: 10.1016/s0730-725x(98)00141-6.

引用本文的文献

1
Macrocyclic complexes of Fe(III) with mixed hydroxypropyl and phenolate or amide pendants as T MRI probes.具有混合羟丙基和酚盐或酰胺侧基的铁(III)大环配合物作为T磁共振成像探针。
Dalton Trans. 2024 Feb 27;53(9):4154-4164. doi: 10.1039/d3dt04013e.
2
Liposomal MRI probes containing encapsulated or amphiphilic Fe(III) coordination complexes.脂质体 MRI 探针,含有包裹或两亲性 Fe(III)配位配合物。
Biomater Sci. 2023 Aug 22;11(17):5942-5954. doi: 10.1039/d3bm00029j.
3
Bioimaging agents based on redox-active transition metal complexes.基于氧化还原活性过渡金属配合物的生物成像剂。

本文引用的文献

1
Defining the conditions for the development of the emerging class of Fe-based MRI contrast agents.确定新型铁基磁共振成像造影剂的发展条件。
Chem Sci. 2021 Jul 26;12(33):11138-11145. doi: 10.1039/d1sc02200h. eCollection 2021 Aug 25.
2
Comparison of phosphonate, hydroxypropyl and carboxylate pendants in Fe(III) macrocyclic complexes as MRI contrast agents.比较膦酸酯、羟丙基和羧酸酯侧基在 Fe(III)大环配合物作为 MRI 造影剂中的性能。
J Inorg Biochem. 2021 Dec;225:111594. doi: 10.1016/j.jinorgbio.2021.111594. Epub 2021 Aug 28.
3
Fe(deferasirox): An Iron(III)-Based Magnetic Resonance Imaging Contrast Agent Endowed with Remarkable Molecular and Functional Characteristics.
Chem Sci. 2022 Jul 27;13(33):9468-9484. doi: 10.1039/d2sc02587f. eCollection 2022 Aug 24.
地拉罗司:一种具有显著分子和功能特性的基于铁(III)的磁共振成像对比剂。
J Am Chem Soc. 2021 Sep 8;143(35):14178-14188. doi: 10.1021/jacs.1c04963. Epub 2021 Aug 25.
4
Dinuclear Fe(III) Hydroxypropyl-Appended Macrocyclic Complexes as MRI Probes.双核 Fe(III) 羟丙基修饰大环配合物作为 MRI 探针。
Inorg Chem. 2021 Jun 21;60(12):8651-8664. doi: 10.1021/acs.inorgchem.1c00634. Epub 2021 Jun 10.
5
Iron(III)-tCDTA derivatives as MRI contrast agents: Increased T relaxivities at higher magnetic field strength and pH sensing.三价铁-三羟甲基丙烷三乙酸盐衍生物作为 MRI 对比剂:在更高磁场强度和 pH 值感应下增加 T1 弛豫率。
Magn Reson Med. 2021 Jun;85(6):3370-3382. doi: 10.1002/mrm.28664. Epub 2021 Feb 4.
6
Relevant Physicochemical Methods to Functionalize, Purify, and Characterize Surface-Decorated Lipid-Based Nanocarriers.相关物理化学方法用于功能化、纯化和表征表面修饰的基于脂质的纳米载体。
Mol Pharm. 2021 Jan 4;18(1):44-64. doi: 10.1021/acs.molpharmaceut.0c00857. Epub 2020 Nov 27.
7
Rational Ligand Design Enables pH Control over Aqueous Iron Magnetostructural Dynamics and Relaxometric Properties.合理配体设计实现了对水相铁磁结构动力学和弛豫性能的 pH 控制。
Inorg Chem. 2020 Dec 7;59(23):17712-17721. doi: 10.1021/acs.inorgchem.0c02923. Epub 2020 Nov 20.
8
The Structures of Gd(III) Chelates Conjugated at the Periphery of 3-(1'-Hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) Have a Significant Impact on the Imaging and Therapy of Cancer.在 3-(1'-己氧基)乙基-3-二乙烯基焦脱镁叶绿酸-a(HPPH)外围连接的 Gd(III)螯合物的结构对癌症的成像和治疗有重大影响。
ChemMedChem. 2020 Nov 4;15(21):2058-2070. doi: 10.1002/cmdc.202000449. Epub 2020 Oct 14.
9
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery.工程化药物载体生物界面以克服药物传递的生物学屏障。
Adv Drug Deliv Rev. 2020 Dec;167:89-108. doi: 10.1016/j.addr.2020.06.007. Epub 2020 Jun 11.
10
Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups.通过附加磺酸基或羟基调节 Fe(III)大环 MRI 对比剂的性质。
Molecules. 2020 May 13;25(10):2291. doi: 10.3390/molecules25102291.